Cancer Immunology

Search results

• What is the key factor in combating severe COVID in older adults?

  Sacha Gnjatic & Miriam Merad

  27/10/22

  1 item of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies | Mount Sinai

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  26/10/22

  1 item of Media coverage

  Press/Media

• New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

  Brian Brown & Miriam Merad

  26/10/22

  1 item of Media coverage

  Press/Media

• Targeting 1 Type of Immune Cell with Another Slows Cancer Growth in Preclinical…

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  26/10/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Hospital: Targeting One Type Of Immune Cell With Another Slows Cancer Growth In Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  26/10/22

  1 item of Media coverage

  Press/Media

• Targeting one type of immune cell with another slows cancer growth in preclinical studies — Science…

  Adam Marks, Luisanna Pia, Miriam Merad, Brian Brown & Alessia Baccarini

  25/10/22

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine: Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  25/10/22

  1 item of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies.

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  25/10/22

  1 item of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia & Miriam Merad

  25/10/22

  65 items of Media coverage

  Press/Media

• Samir Parekh, MD, on Improving Survival in Multiple Myeloma With Sequential T-Cell Redirection Therapies

  Samir Parekh

  17/10/22

  1 item of Media coverage

  Press/Media

• Can Technology Make Humans ‘Super’?

  Brian Brown & Alessia Baccarini

  13/10/22

  1 item of Media coverage

  Press/Media

• Researchers identify immune cell that helps kill bladder cancer tumors

  Nina Bhardwaj

  7/10/22

  1 item of Media coverage

  Press/Media

• Researchers identify flu-fighting pathways and genes essential for influenza A immune defense

  Shashank Tripathi , Christian Forst & Adolfo Garcia-Sastre

  6/10/22 → 7/10/22

  2 items of Media coverage

  Press/Media

• United States: Immune Cell Dysregulation: COVID Severity

  Sacha Gnjatic & Miriam Merad

  6/10/22 → 7/10/22

  2 items of Media coverage

  Press/Media

• Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense

  Shashank Tripathi , Christian Forst & Adolfo Garcia-Sastre

  5/10/22 → 6/10/22

  71 items of Media coverage

  Press/Media

• Mount Sinai Hospital: Study Provides Further Evidence That Immune Cell Dysregulation Is A Driver Of COVID-19 Severity

  Sacha Gnjatic & Miriam Merad

  5/10/22

  1 item of Media coverage

  Press/Media

• Health News. Joshua Damien Cordle

  Sacha Gnjatic & Miriam Merad

  5/10/22

  1 item of Media coverage

  Press/Media

• Researchers Identify Flu-Fighting Pathways and Genes Essential for Influenza A Immune Defense.

  Shashank Tripathi , Christian Forst & Adolfo Garcia-Sastre

  5/10/22

  2 items of Media coverage

  Press/Media

• Immune Cell Dysregulation: COVID Severity

  Sacha Gnjatic & Miriam Merad

  5/10/22

  1 item of Media coverage

  Press/Media

• Study provides further evidence that immune cell dysregulation is a driver of COVID-19 severity

  Sacha Gnjatic & Miriam Merad

  4/10/22

  4 items of Media coverage

  Press/Media

• Study Provides Further Evidence That Immune Cell Dysregulation is a Driver of COVID-19 Severity

  Alexander Charney, Sacha Gnjatic & Miriam Merad

  4/10/22

  2 items of Media coverage

  Press/Media

• -University of Virginia : UVA DISCOVERY COULD POWER UP PLATELET PRODUCTION TO BATTLE BLOOD SHORTAGES

  Camelia Iancu-Rubin & Camelia Iancu-Rubin

  30/09/22

  2 items of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma (CC-220)

  Samir Parekh

  29/09/22

  1 item of Media coverage

  Press/Media

• UVA Discovery Could Power Up Platelet Production To Battle Blood Shortages

  Camelia Iancu-Rubin & Camelia Iancu-Rubin

  29/09/22

  1 item of Media coverage

  Press/Media

• UVA Discovery Could Power Up Platelet Production to Battle Blood Shortages

  Camelia Iancu-Rubin & Camelia Iancu-Rubin

  28/09/22

  1 item of Media coverage

  Press/Media